Platelet c‐mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value
- 1 October 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (1) , 139-147
- https://doi.org/10.1046/j.1365-2141.1999.01667.x
Abstract
Essential thrombocythaemia (ET) can be difficult to discriminate from an occult case of reactive thrombocytosis (RT). Since thrombopoietin (TPO) is the primary regulator of thrombopoiesis, we have investigated whether levels of TPO and/or its receptor, c‐mpl, are of value in the differential diagnosis of ET. Plasma TPO levels in patients with ET, RT and other myeloproliferative disorders (MPDs) did not differ significantly from normal controls. However, surface c‐mpl expression was significantly reduced in platelets from 18 ET patients, 0–65.5% of controls (P < 0.001). Immunoblots on five of these and five additional patients were consistent with absent or reduced c‐mpl protein levels. The surface c‐mpl expression results were significantly different from those in eight RT patients (21.3–95.5%, P = 0.0015), but there was considerable overlap between the two groups and a reduced level was not restricted to ET. Furthermore, c‐mpl expression in ET patients was not different from eight patients with other MPDs (0–87.6%, P = 0.06), nor could it differentiate between ET patients with monoclonal and polyclonal haemopoiesis. Although a low or absent c‐mpl level is suggestive of a primary rather than a secondary thrombocytosis, it is insufficiently discriminatory to be used as a diagnostic marker for ET.Keywords
This publication has 34 references indexed in Scilit:
- ThrombopoietinNew England Journal of Medicine, 1998
- The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non‐familial essential thrombocythaemiaBritish Journal of Haematology, 1998
- Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia VeraNew England Journal of Medicine, 1998
- An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemiaNature Genetics, 1998
- Analysis of Thrombopoietin andc-mplExpression in a Child with Essential ThrombocythemiaPediatric Hematology and Oncology, 1998
- Study of the thrombopoietin receptor in essential thrombocythemiaLeukemia, 1997
- Defective response to thrombopoietin and impaired expression of c‐mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 1997
- A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disordersBritish Journal of Haematology, 1996
- Levels of Serum Granulocyte Colony-Stimulating Factor in Patients with Chronic Myeloid LeukemiaLeukemia & Lymphoma, 1993
- Determination of Serum Immunoreactive Erythropoietin in the Investigation of ErythrocytosisNew England Journal of Medicine, 1986